Inhibiting aldose reductase limits NF-κB activation and proinflammatory gene expression in response to hyperglycemia and proinflammatory cytokines, suggesting aldose reductase plays a proinflammatory function in endothelial cells [205, 206]. The gene discussed is AKR1B1; the disease is Hyperglycemia.